(S)-3-(hydroxymethyl)-N-((S)-1-(naphthalen-1-yl)ethyl)pent-4-enamide, 97%, 100mg

3-(Toluene-4-sulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester, 1g

2-BROMO-4-CHLOROPYRIDIN-3-OL, 95.0%, 100mg

2-amino-5,6-dimethyl-4-pyrimidinol, 95.0%, 10g

3-(Hydroxymethyl)phenylboronic acid, 98.0%, 1g

Fmoc-Val-Ala-PAB-PNP, 1g

N,N-Dimethyl-2-((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)oxy)ethanamine, 95.0%, 5g

N-(2,4-Dimethoxyphenyl)-3-oxobutanamide, 97%, 100g

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride, 95.0%, 5g

3-(Tetrahydro-2H-pyran-4-yl)indoline-5-carboxylic acid, 97%, 500mg

Lithium tert-Butoxide (ca. 10% in Tetrahydrofuran, ca. 1mol/L)100mL

Guko sleeves ROTILABO®, 41 mm, 27.5 mm, 1 Piece

1-Phenyl-3-(2,4,6-trimethylphenyl)-2-pyrazoline>98.0%(GC)5g